3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Completed
26
Unknown
9
Recruiting
9
Not yet recruiting
5
Active not recruiting
4
Withdrawn
2
Terminated
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Head & Neck
1
Breast
1
Conditions
Breast Neoplasms
370
Neoplasms
253
Carcinoma, Non-Small-Cell Lung
224
Prostatic Neoplasms
192
Lung Neoplasms
142
Colorectal Neoplasms
139
Neoplasm Metastasis
132
Pancreatic Neoplasms
131
Leukemia, Myeloid, Acute
126
Multiple Myeloma
123
Lymphoma
115
Carcinoma, Hepatocellular
111
Ovarian Neoplasms
98
Melanoma
97
Recurrence
93
Leukemia
89
Head and Neck Neoplasms
89
Leukemia, Lymphocytic, Chronic, B-Cell
86
Brain Neoplasms
86
Precursor Cell Lymphoblastic Leukemia-Lymphoma
79
Glioblastoma
77
Lymphoma, Non-Hodgkin
73
Squamous Cell Carcinoma of Head and Neck
71
Lymphoma, Follicular
70
Lymphoma, Large B-Cell, Diffuse
66
Colonic Neoplasms
66
Carcinoma, Renal Cell
62
Hematologic Neoplasms
59
Sarcoma
55
Glioma
53
Interventions
Gabapentin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Withdrawn
×
Interventional
×
Neuralgia
×
Clear all
NCT03747562
2024-09-19
stREnGTH
University Hospital, Ghent
Phase 3
Withdrawn
NCT02944721
2017-11-14
DOLORISKSEIN
Hopital Foch
Phase NA
Withdrawn